Northern Trust Corp Opti Nose, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Opti Nose, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 638,133 shares of OPTN stock, worth $427,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares

638,133

Previous 620,393 2.86%

Holding current value

$427,549

Previous $905,000 26.74%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.82 - $1.44 $14,546 - $25,545	17,740 Added 2.86%	638,133 $663,000
Q1 2024 May 14, 2024	BUY	$1.17 - $1.94 $5,972 - $9,903	5,105 Added 0.83%	620,393 $905,000
Q4 2023 Feb 13, 2024	BUY	$1.02 - $1.47 $2,429 - $3,501	2,382 Added 0.39%	615,288 $793,000
Q3 2023 Nov 13, 2023	BUY	$0.93 - $1.38 $19,295 - $28,632	20,748 Added 3.5%	612,906 $753,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $2.05 $531,436 - $981,482	478,772 Added 422.25%	592,158 $728,000
Q1 2023 May 15, 2023	BUY	$1.63 - $2.02 $15,100 - $18,713	9,264 Added 8.9%	113,386 $218,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $32,108 - $37,537	-9,361 Reduced 8.25%	104,122 $381,000
Q2 2022 Aug 12, 2022	BUY	$1.76 - $3.82 $2,662 - $5,779	1,513 Added 1.35%	113,483 $415,000
Q1 2022 May 13, 2022	BUY	$1.77 - $2.93 $80,869 - $133,868	45,689 Added 68.93%	111,970 $277,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.16 $3,957 - $5,321	-1,684 Reduced 2.48%	66,281 $199,000
Q2 2021 Aug 13, 2021	SELL	$2.91 - $3.83 $894,598 - $1.18 Million	-307,422 Reduced 81.89%	67,965 $211,000
Q1 2021 May 12, 2021	SELL	$3.47 - $4.75 $42,854 - $58,662	-12,350 Reduced 3.19%	375,387 $1.39 Million
Q4 2020 Feb 11, 2021	BUY	$3.2 - $4.98 $10,521 - $16,374	3,288 Added 0.86%	387,737 $1.61 Million
Q3 2020 Nov 16, 2020	BUY	$3.69 - $7.09 $58,859 - $113,092	15,951 Added 4.33%	384,449 $1.5 Million
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $121,748 - $253,019	34,008 Added 10.17%	368,498 $2.74 Million
Q1 2020 May 14, 2020	BUY	$3.49 - $9.2 $108,668 - $286,460	31,137 Added 10.26%	334,490 $1.5 Million
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $94,501 - $171,971	15,072 Added 5.23%	303,353 $2.8 Million
Q3 2019 Nov 13, 2019	BUY	$4.75 - $8.38 $287,740 - $507,635	60,577 Added 26.6%	288,281 $2.02 Million
Q2 2019 Aug 13, 2019	BUY	$6.4 - $10.94 $11,500 - $19,659	1,797 Added 0.8%	227,704 $1.61 Million
Q1 2019 May 13, 2019	SELL	$6.1 - $10.3 $53,490 - $90,320	-8,769 Reduced 3.74%	225,907 $2.33 Million
Q4 2018 Feb 12, 2019	SELL	$5.84 - $11.92 $7,568 - $15,448	-1,296 Reduced 0.55%	234,676 $1.46 Million
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $599,138 - $1.43 Million	48,201 Added 25.67%	235,972 $2.93 Million
Q2 2018 Sep 18, 2018	SELL	$18.75 - $28.46 $45,018 - $68,332	-2,401 Reduced 1.26%	187,771 $5.25 Million
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $2.08 Million - $3.16 Million	111,100 Added 140.5%	190,172 $5.32 Million
Q1 2018 May 09, 2018	BUY	$15.91 - $20.82 $67,553 - $88,401	4,246 Added 5.67%	79,072 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$15.2 - $20.76 $1.14 Million - $1.55 Million	74,826	74,826 $1.41 Million

Others Institutions Holding OPTN

# of Institutions

Shares Held

85.2M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $55.8M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Opti Nose, Inc. Transaction History